- Home
- PLAG vs INM Comparison
PLAG vs INM Comparison
Compare PLAG & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLAG | INM |
|---|---|---|
| Founded | 1986 | 1981 |
| Country | United States | Canada |
| Employees | 6 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 8.8M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PLAG | INM |
|---|---|---|
| Price | $0.35 | $14.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 64.4K |
| Earning Date | 11-17-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.56 | ★ 62.68 |
| EPS | ★ N/A | N/A |
| Revenue | $3,040,616.00 | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.21 | $0.58 |
| 52 Week High | $6.81 | $2.33 |
Technical Indicators
Market Signals| Indicator | PLAG | INM |
|---|---|---|
| Relative Strength Index (RSI) | 30.45 | 99.23 |
| Support Level | $0.21 | $1.00 |
| Resistance Level | $0.77 | N/A |
| Average True Range (ATR) | 0.06 | 0.50 |
| MACD | -0.00 | 1.24 |
| Stochastic Oscillator | 33.85 | 84.72 |
Price Performance
Historical ComparisonAbout PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.